Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD
Status:
Terminated
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
Phase II efficacy evaluation, phase I/II efficacy and toxicity trial of recombinant human
keratinocyte growth factor for the treatment of steroid refractory gastrointestinal graft
versus host disease.